• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Microbial Lipase Market

    ID: MRFR/F-B & N/17083-HCR
    128 Pages
    Garvit Vyas
    October 2025

    US Microbial Lipase Market Research Report: By Source (Bacteria, Fungi) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Microbial Lipase Market Infographic
    Purchase Options

    US Microbial Lipase Market Summary

    The US Microbial Lipase market is projected to grow significantly from 103.8 million USD in 2024 to 196.4 million USD by 2035.

    Key Market Trends & Highlights

    US Microbial Lipase Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate of 5.97 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 196.4 million USD, indicating robust growth potential.
    • In 2024, the market is valued at 103.8 million USD, reflecting a strong foundation for future expansion.
    • Growing adoption of microbial lipase in various industries due to its efficiency in biocatalysis is a major market driver.

    Market Size & Forecast

    2024 Market Size 103.8 (USD Million)
    2035 Market Size 196.4 (USD Million)
    CAGR (2025-2035) 5.97%

    Major Players

    Biocatalysts, AB Enzymes, Bigelow Chemicals, Amano Enzyme, Advanced Enzyme Technologies, Rochester Midland Corporation, BASF, DSM, Kraton Corporation, Genomatica, Chr. Hansen, SABIC, Novozymes, DuPont, Enzyme Development Corporation

    US Microbial Lipase Market Trends

    The US Microbial Lipase Market is experiencing significant growth driven by several key market drivers. The rising demand for enzymes in the food and beverage industry is a notable factor, as microbial lipases are increasingly used in the production of dairy products, baked goods, and plant-based products. Additionally, the growing trend towards healthier eating habits has fueled the search for enzyme-based solutions that enhance nutritional profiles without compromising on flavor. The food processing sector in the US is adapting to these changes, seeking efficient production methods that include the use of microbial lipase to improve fat utilization and product consistency.

    There are ample opportunities to be explored in the realm of biofuels and animal feed applications as well. With the push for more sustainable practices, the use of microbial lipase in biodiesel production is gaining attention. Furthermore, incorporating microbial lipase into animal feed can improve fat metabolism and overall animal health, making it an appealing option for livestock producers. Research into novel microbial strains and their enzymatic properties presents another frontier for innovation, potentially allowing the development of lipases that can operate effectively under various environmental conditions.

    In recent times, the US has seen an uptick in research and development initiatives focused on enzyme technology.With a strong emphasis on biotechnology, academic and industrial collaborations are on the rise, leading to innovations that can transform product formulations in various industries beyond food, such as pharmaceuticals and cosmetics. This trend reflects the US commitment to advancing enzyme applications, aligning with federal support for biomanufacturing efforts as part of broader sustainability goals. As the microbial lipase market continues to expand, staying attuned to these developments will be vital for stakeholders aiming to capitalize on future opportunities.

    Market Segment Insights

    Microbial Lipase Market Source Insights

    The US Microbial Lipase Market has been witnessing a notable expansion as a result of the increasing demand for various applications, particularly in the food, pharmaceutical, and biofuel industries. The Source segment, which includes categories such as Bacteria and Fungi, plays a pivotal role in determining the product diversity and potency in the microbial lipase sector.

    Bacteria, particularly those derived from species like Pseudomonas and Bacillus, are known for their ability to produce lipases with a broad range of enzymatic activity and stability, making them essential for industrial applications.On the other hand, Fungi also contribute significantly to the US Microbial Lipase Market by producing enzymes that are crucial in the bioconversion of lipids into free fatty acids. This process is essential for biodiesel production, enhancing its market relevance as sustainable energy sources gain traction in response to the pressing demand for renewable energy alternatives.

    Each of these sources has distinct advantages; for instance, fungal lipases tend to operate effectively in a wider pH range, which broadens their application potential across different industries. As consumer preference shifts towards healthier food options and more sustainable production methods, the utilization of microbial lipases derived from these sources is expected to grow. Opportunities also abound as innovation in enzyme engineering and biotechnology unlocks new capabilities in lipase production.

    The thriving food processing industry in the US is driving the demand for microbial lipases, as they play a critical role in flavor enhancement, aroma development, and the fat modification processes in various food products.

    The diversity within the Source segment significantly enriches the overall landscape of the US Microbial Lipase Market, ensuring that it is well-positioned to meet the versatility required by various industrial applications.Thus, as the industry adapts to evolving consumer preferences and technological advancements, the emphasis on optimizing bacterial and fungal lipase production capabilities will be crucial in sustaining market growth and meeting the evolving needs across sectors.

    Get more detailed insights about US Microbial Lipase Market Research Report — Forecast till 2035

    Key Players and Competitive Insights

    The US Microbial Lipase Market represents a dynamic sector with notable competitive insights, shaped by rapidly evolving consumer preferences, technological advancements, and increased awareness about the benefits of microbial lipases in various applications. The interest in biocatalysts has been growing significantly, fueled by the demand for sustainable and efficient enzyme solutions in food, animal feed, and other industrial applications. As companies strive to capture market share, they emphasize innovation, quality, and strategic collaborations to enhance their product offerings.

    The market landscape is characterized by several players striving to differentiate themselves through product innovation and customer engagement strategies, thereby intensifying competition and driving growth in this niche enzyme market.In the context of the US Microbial Lipase Market, Biocatalysts has emerged as a prominent contender known for its substantial presence. The company's strength lies in its extensive experience and expertise in enzyme technology, offering tailored solutions that meet consumer needs effectively. By maintaining high-quality standards and investing in research and development, Biocatalysts has successfully positioned itself as a reliable provider of microbial lipase enzymes.

    Additionally, their collaborative approach with customers enables them to offer customized solutions, thereby enhancing their competitive edge. Their commitment to sustainability and the production of bio-based products aligns well with the increasing demand for green technologies in the market, further solidifying their position within the industry. AB Enzymes has established a significant footprint in the US Microbial Lipase Market, presenting a range of key products and services that cater to diverse industrial applications. Known for their innovative enzymatic solutions, AB Enzymes successfully leverages advanced biotechnology to develop microbial lipases that enhance process efficiency and product quality.

    The company's strength lies in its robust research and development initiatives, which enable them to stay at the forefront of enzyme innovation. Their market presence is reinforced through strategic partnerships and collaborations aimed at expanding their reach within various sectors. Moreover, AB Enzymes has engaged in strategic mergers and acquisitions, which have facilitated the enhancement of their product portfolio and strengthened their operational capabilities in the US market. This proactive approach to growth, combined with their focus on sustainability, has positioned AB Enzymes as a formidable player within the US Microbial Lipase Market.

    Key Companies in the US Microbial Lipase Market market include

    Industry Developments

    The US Microbial Lipase Market has witnessed significant developments recently, with increased investments in biotechnology and food applications driving growth. Notably, in June 2023, Novozymes expanded its microbial enzyme portfolio to enhance its operational efficiency and product offerings, while BASF announced advancements in lipase formulations to improve performance in food processing applications. Furthermore, DuPont is focusing on sustainable practices in its Microbial Lipase production, aligning with US regulatory initiatives aimed at promoting eco-friendly products. In terms of mergers and acquisitions, Amano Enzyme acquired specific enzyme technologies from a competitor in August 2023, strengthening its position in the microbial lipase sector.

    The market has also seen major happenings, such as the report released in March 2022 indicating a rising demand for microbial lipases in the bakery and dairy industries, supporting the sustenance of high growth rates. Additionally, the market valuation of companies has been positively impacted by integrating innovative technologies, such as Kraton Corporation's partnership with Genomatica for sustainable chemical applications, which reflects a broader trend of environmental consciousness among key players in the market.

    Market Segmentation

    Outlook

    • Bacteria
    • Fungi

    Report Scope

    Report Scope:
    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 97.47(USD Million)
    MARKET SIZE 2024 103.8(USD Million)
    MARKET SIZE 2035 196.42(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 5.969% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Biocatalysts, AB Enzymes, Bigelow Chemicals, Amano Enzyme, Advanced Enzyme Technologies, Rochester Midland Corporation, BASF, DSM, Kraton Corporation, Genomatica, Chr. Hansen, SABIC, Novozymes, DuPont, Enzyme Development Corporation
    SEGMENTS COVERED Source
    KEY MARKET OPPORTUNITIES Growing demand for biofuels, Expanding food industry applications, Increasing health consciousness trends, Rising demand in detergents, Advancement in enzyme technology
    KEY MARKET DYNAMICS growing demand for bio-based products, increasing applications in food industry, advancements in enzymatic processes, rising awareness about health benefits, expansion in detergent formulation
    COUNTRIES COVERED US

    FAQs

    What is the expected market size of the US Microbial Lipase Market in 2024?

    The US Microbial Lipase Market is expected to be valued at 103.8 million USD in 2024.

    What is the projected market value for the US Microbial Lipase Market by 2035?

    By 2035, the US Microbial Lipase Market is projected to reach a value of 196.42 million USD.

    What is the expected CAGR for the US Microbial Lipase Market from 2025 to 2035?

    The expected compound annual growth rate (CAGR) for the market from 2025 to 2035 is 5.969%.

    Which segment of the US Microbial Lipase Market is expected to dominate in 2024?

    In 2024, the fungi segment is expected to dominate the US Microbial Lipase Market with a value of 65.4 million USD.

    What is the projected market size for the bacteria segment by 2035?

    The bacteria segment is projected to reach a size of 72.5 million USD by 2035.

    Who are the key players in the US Microbial Lipase Market?

    Major players in the US Microbial Lipase Market include Biocatalysts, AB Enzymes, and Novozymes.

    What are the application areas driving growth in the US Microbial Lipase Market?

    The growth in the market is primarily driven by applications in food processing, detergents, and pharmaceuticals.

    How are global economic conditions currently impacting the US Microbial Lipase Market?

    Current global economic conditions may lead to fluctuations in market growth due to supply chain challenges and demand changes.

    What is the projected size of the fungi segment in the US Microbial Lipase Market by 2035?

    The fungi segment is expected to be valued at 123.92 million USD by 2035.

    What growth opportunities are emerging in the US Microbial Lipase Market?

    Emerging opportunities in the market include advancements in biotechnology and increasing demand for biocatalysts in various industries.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials